Patient Registry Software Market Size, Share & Trends Analysis By Registry Type, By Software Type, By Pricing Model, By Deployment Model, By type of Database, By Functionality, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Global patient registry software market is projected to worth USD 3.2 Bn by 2030
According to SPER Market Research, the global patient registry software market was valued at USD 1.5 Bn in 2021 and estimated to reach USD 3.2 Bn by 2030 with a CAGR of 14.8%. Globally, a shift towards computerized registries is encouraged to make storage, sorting, reporting of data convenient for use in quality improvement, planning and delivery of direct care.
Impact of COVID-19 on the Patient Registry Software Market
The demand for patient registry software has substantially increased since the inception of COVID-19 infection across the globe. The patient registries help the healthcare providers understand the prognosis of disease and improve the effectiveness of treatments for varied population through the real clinical data derived from registries of patients across the globe. These registries help the healthcare providers to ensure personalized treatment to the patients through the access to their predetermined health problems, allergies and contraindications.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Registry type, By Software type, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User
Geographies covered
North America, Europe, APAC, Latin America, and the Middle East & Africa
Companies Covered
ArborMetrix, Armus, Cedaron, Conduent, Inc., Dacima Software, Elekta AB, ESO Solutions, Evado Clinical, FIGmd, Global Vision Technologies, IBM Corporation, ifa Systems AG, ImageTrend, IQVIA Holdings, Lumdex, McKesson Corporation, Medstreaming- M2S, OpenText Corporation, Optum, Ordinal Data Inc., Phamax AG, Premier, Inc., Syneos Health, Versaform Systems Corp, WIRB Copernicus Group
Driver: Growing adoption of EHRs
The adoption of electronic health records is increasing across the globe in order to improve patient care and store patient’s data on digital platforms. The EHRs products often include patient registry software or are compliant to add-on patient registry software. The worldwide transition to computerized records from paper-based storage is a leading driver for the patient registry software market.
Challenge: Unwillingness to adapt computerized registry
In developing countries, the paper-based registry tools are continuing to exit. In many rural areas, hospitals rely on spreadsheets or paper registries to maintain the record of patient’s data. The cost associated with adoption of EHRs also restrict the hospitals and physician to adopt patient registry software and pose as a significant challenge to the growth of patient registry software market.
Opportunity: Emergence of cloud-based registry solutions
Cloud-based patient registry solutions are providing improved data accessibility, user-friendly interface, and real time analysis. The data from cloud-based registry solutions can be extracted without any limitations to time, place or platform. The advantages offered by cloud-based solutions provide great opportunities to the growth of patient registry software market.
Patient Registry Software Market by Registry type:
Based on registry type, market has been segmented into disease registries, health service registries, product registries
Patient Registry Software Market by Software type:
Based on software type, the market is segmented into standalone software, integrated software
Patient Registry Software Market by Pricing Model:
Based on pricing model, the market is segmented into subscription model and ownership model.
Patient Registry Software Market by Deployment Model:
Based on deployment model, the market is segmented into on-premise models and web & cloud-based models.
Patient Registry Software Market by Database type:
Based on database type, the market is segmented into commercial databases, public databases.
Patient Registry Software Market by Functionality:
Based on functionality, the market is segmented into population health management, patient care management, health information exchange, point-of-care, product outcome evaluation, medical research & clinical studies.
Patient Registry Software Market by End User:
Based on End User, the market is segmented into government organizations & third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology and medical device companies and research centers.
The government organizations & third-party administrators dominated the share of patient registry sodtware market by end user owing to emergence of global pandemic and urgent need of patient registry software to provide better patient health management.
Patient Registry Software Market by Region:
North America owns the largest share of this market due to supportive government schemes, technological advancements and adoption of patient registry software for population health management.
According to SPER Market Research, the global patient registry software market was valued at USD 1.5 Bn in 2021 and estimated to reach USD 3.2 Bn by 2030 with a CAGR of 14.8%. Globally, a shift towards computerized registries is encouraged to make storage, sorting, reporting of data convenient for use in quality improvement, planning and delivery of direct care.
Impact of COVID-19 on the Patient Registry Software Market
The demand for patient registry software has substantially increased since the inception of COVID-19 infection across the globe. The patient registries help the healthcare providers understand the prognosis of disease and improve the effectiveness of treatments for varied population through the real clinical data derived from registries of patients across the globe. These registries help the healthcare providers to ensure personalized treatment to the patients through the access to their predetermined health problems, allergies and contraindications.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Registry type, By Software type, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User
Geographies covered
North America, Europe, APAC, Latin America, and the Middle East & Africa
Companies Covered
ArborMetrix, Armus, Cedaron, Conduent, Inc., Dacima Software, Elekta AB, ESO Solutions, Evado Clinical, FIGmd, Global Vision Technologies, IBM Corporation, ifa Systems AG, ImageTrend, IQVIA Holdings, Lumdex, McKesson Corporation, Medstreaming- M2S, OpenText Corporation, Optum, Ordinal Data Inc., Phamax AG, Premier, Inc., Syneos Health, Versaform Systems Corp, WIRB Copernicus Group
Driver: Growing adoption of EHRs
The adoption of electronic health records is increasing across the globe in order to improve patient care and store patient’s data on digital platforms. The EHRs products often include patient registry software or are compliant to add-on patient registry software. The worldwide transition to computerized records from paper-based storage is a leading driver for the patient registry software market.
Challenge: Unwillingness to adapt computerized registry
In developing countries, the paper-based registry tools are continuing to exit. In many rural areas, hospitals rely on spreadsheets or paper registries to maintain the record of patient’s data. The cost associated with adoption of EHRs also restrict the hospitals and physician to adopt patient registry software and pose as a significant challenge to the growth of patient registry software market.
Opportunity: Emergence of cloud-based registry solutions
Cloud-based patient registry solutions are providing improved data accessibility, user-friendly interface, and real time analysis. The data from cloud-based registry solutions can be extracted without any limitations to time, place or platform. The advantages offered by cloud-based solutions provide great opportunities to the growth of patient registry software market.
Patient Registry Software Market by Registry type:
Based on registry type, market has been segmented into disease registries, health service registries, product registries
Patient Registry Software Market by Software type:
Based on software type, the market is segmented into standalone software, integrated software
Patient Registry Software Market by Pricing Model:
Based on pricing model, the market is segmented into subscription model and ownership model.
Patient Registry Software Market by Deployment Model:
Based on deployment model, the market is segmented into on-premise models and web & cloud-based models.
Patient Registry Software Market by Database type:
Based on database type, the market is segmented into commercial databases, public databases.
Patient Registry Software Market by Functionality:
Based on functionality, the market is segmented into population health management, patient care management, health information exchange, point-of-care, product outcome evaluation, medical research & clinical studies.
Patient Registry Software Market by End User:
Based on End User, the market is segmented into government organizations & third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology and medical device companies and research centers.
The government organizations & third-party administrators dominated the share of patient registry sodtware market by end user owing to emergence of global pandemic and urgent need of patient registry software to provide better patient health management.
Patient Registry Software Market by Region:
North America owns the largest share of this market due to supportive government schemes, technological advancements and adoption of patient registry software for population health management.
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Patient Registry Software Market
4.4. Market Trends
5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2030 (USD MILLION)
5.1. Disease Registry
5.1.1. Diabetes Registries
5.1.2. Cardiovascular Registries
5.1.3. Cancer Registries
5.1.4. Rare Disease Registries
5.1.5. Asthma Registries
5.1.6. Chronic Kidney Registries
5.1.7. Orthopedic Registries
5.1.8. Other Disease Registries
5.2. Health Service Registries
5.3. Product Registries
5.3.1. Medical Device Registries
5.3.2. Drug Registries
6. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2030 (USD MILLION)
6.1. Standalone Software
6.2. Integrated Software
7. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2021-2030 (USD MILLION)
7.1. Subscription Model
7.2. Ownership Model
8. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2021-2030 (USD MILLION)
8.1. On-premise Model
8.2. Web & Cloud-based Models
9. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2021-2030 (USD MILLION)
9.1. Commercial Databases
9.2. Public Databases
10. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
10.1. Population Health Management
10.2. Patient Care Management
10.3. Health Information Exchange
10.4. Point-of-Care
10.5. Production Outcome Evaluation
10.6. Medical Research & Clinical Studies
11. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION)
11.1. Government Organizations & Third-party Administrators
11.2. Hospitals and Medical Practices
11.3. Private Payers
11.4. Pharmaceuticals, Biotechnology, and Medical Device Companies
11.5. Research Centers
12. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY GEOGRAPHY, 2021-2030 (USD MILLION)
12.1. North America
12.1.1. US
12.1.2. Canada
12.2. Europe
12.2.1. Germany
12.2.2. UK
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Rest of Europe
12.3. Asia-Pacific
12.3.1. China
12.3.2. Japan
12.3.3. India
12.3.4. Rest of Asia-Pacific
12.4. Rest of the World
12.4.1. Latin America
12.4.2. Middle East & Africa
13. COMPETITIVE LANDSCAPE
13.1. Introduction
13.2. Market Share Analysis, By Key Players (2021)
13.3. Competitive Scenario
13.3.1. Product Launches
13.3.2. Partnerships, Collaborations and Agreements
13.3.3. Acquisitions
13.3.4. Expansions
13.3.5. Other Developments
14. COMPANY PROFILES
14.1. ArborMetrix
14.2. Armus
14.3. Cedaron
14.4. Conduent, Inc.
14.5. Dacima Software
14.6. Elekta AB
14.7. ESO Solutions
14.8. Evado Clinical
14.9. FIGmd
14.10. Global Vision Technologies
14.11. IBM Corporation
14.12. ifa Systems AG
14.13. ImageTrend
14.14. IQVIA Holdings
14.15. Lumdex
14.16. McKesson Corporation
14.17. Medstreaming- M2S
14.18. OpenText Corporation
14.19. Optum
14.20. Ordinal Data Inc.
14.21. Phamax AG
14.22. Premier, Inc.
14.23. Syneos Health
14.24. Versaform Systems Corp
14.25. WIRB Copernicus Group
15. APPENDIX
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Patient Registry Software Market
4.4. Market Trends
5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2030 (USD MILLION)
5.1. Disease Registry
5.1.1. Diabetes Registries
5.1.2. Cardiovascular Registries
5.1.3. Cancer Registries
5.1.4. Rare Disease Registries
5.1.5. Asthma Registries
5.1.6. Chronic Kidney Registries
5.1.7. Orthopedic Registries
5.1.8. Other Disease Registries
5.2. Health Service Registries
5.3. Product Registries
5.3.1. Medical Device Registries
5.3.2. Drug Registries
6. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2030 (USD MILLION)
6.1. Standalone Software
6.2. Integrated Software
7. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2021-2030 (USD MILLION)
7.1. Subscription Model
7.2. Ownership Model
8. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2021-2030 (USD MILLION)
8.1. On-premise Model
8.2. Web & Cloud-based Models
9. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2021-2030 (USD MILLION)
9.1. Commercial Databases
9.2. Public Databases
10. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
10.1. Population Health Management
10.2. Patient Care Management
10.3. Health Information Exchange
10.4. Point-of-Care
10.5. Production Outcome Evaluation
10.6. Medical Research & Clinical Studies
11. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION)
11.1. Government Organizations & Third-party Administrators
11.2. Hospitals and Medical Practices
11.3. Private Payers
11.4. Pharmaceuticals, Biotechnology, and Medical Device Companies
11.5. Research Centers
12. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY GEOGRAPHY, 2021-2030 (USD MILLION)
12.1. North America
12.1.1. US
12.1.2. Canada
12.2. Europe
12.2.1. Germany
12.2.2. UK
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Rest of Europe
12.3. Asia-Pacific
12.3.1. China
12.3.2. Japan
12.3.3. India
12.3.4. Rest of Asia-Pacific
12.4. Rest of the World
12.4.1. Latin America
12.4.2. Middle East & Africa
13. COMPETITIVE LANDSCAPE
13.1. Introduction
13.2. Market Share Analysis, By Key Players (2021)
13.3. Competitive Scenario
13.3.1. Product Launches
13.3.2. Partnerships, Collaborations and Agreements
13.3.3. Acquisitions
13.3.4. Expansions
13.3.5. Other Developments
14. COMPANY PROFILES
14.1. ArborMetrix
14.2. Armus
14.3. Cedaron
14.4. Conduent, Inc.
14.5. Dacima Software
14.6. Elekta AB
14.7. ESO Solutions
14.8. Evado Clinical
14.9. FIGmd
14.10. Global Vision Technologies
14.11. IBM Corporation
14.12. ifa Systems AG
14.13. ImageTrend
14.14. IQVIA Holdings
14.15. Lumdex
14.16. McKesson Corporation
14.17. Medstreaming- M2S
14.18. OpenText Corporation
14.19. Optum
14.20. Ordinal Data Inc.
14.21. Phamax AG
14.22. Premier, Inc.
14.23. Syneos Health
14.24. Versaform Systems Corp
14.25. WIRB Copernicus Group
15. APPENDIX
